2m 2m 2m 2m 2m 2m 2m
VERAXA BIOTECH N (VRXA)
NASDAQ
$2.91-$0.004 (-0.14%)
Price as of Jun 23, 2026 7:57 PM EDT- $585.4MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
VERAXA BIOTECH N (VRXA)
$2.91-$0.004 (-0.14%)
VRXA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.91 | ||
Change | -$1.23 (-29.71%) | ||
Open | $3.90 | ||
High | $3.90 | ||
Low | $2.80 | ||
Previous Close | $4.14 | ||
Volume | 817,717 | ||
30-Day Average Volume | 455,952 | ||
1-Week Change | -69.24% | ||
1-Month Change | N/A | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 141.4M | ||
Total Assets | $101,000.00 | ||
Market Cap | $585.4M | ||
Enterprise Value | $585.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue